1.The Agreement between State-Trait-Anxiety-Inventory (STAI) and Beck Anxiety Inventory (BAI) on Measuring Anxiety Level Among Adult Patients Before Venepuncture Procedure
Izzaty Dalawi ; Mohamad Rodi Isa ; Faizul Haris Mohd Hatta ; Muhammad Fairuz Rahmat
Malaysian Journal of Medicine and Health Sciences 2023;19(No.3):254-261
Introduction: Venepuncture procedure is painful and anxiety associated with venepuncture is common. There are
many tools for assessing anxiety levels in an outpatient setting. Hence, this study is to compare the degree of agreement between State-Trait-Anxiety-Inventory (STAI) and Beck Anxiety Inventory (BAI) for measuring anxiety levels
among adult patients before venepuncture procedure. Methods: A cross-sectional pilot study was conducted among
patients while waiting for a venepuncture procedure in the Phlebotomy Unit, UiTMMC in April 2020. The Malay-validated version of the State-Trait-Anxiety-Inventory (STAI) and Beck Anxiety Inventory (BAI) were used to assess the anxiety level. Differences between sets of data were plotted as described by Bland-Altman to determine the
agreement between these two assessment tools. Results: A total of 330 patients participated in the study with a mean
age of 46.34 ± 14.34 years old and gender was equally distributed. The scores of state-anxiety (STAI-S), trait-anxiety
(STAI-T) and BAI score were 30.04 ± 20.74; 29.51 ± 19.11; and 40.98 ± 20.45, respectively. The score of anxiety
using BAI was higher compared to STAI-S (p<0.001) and STAI-T (p<0.001). The mean difference between the STAI-S
and BAI was -10.94 (95%CI: -53.01, 26.87) and between the STAI-T and BAI was -11.47 (95%CI: -42.26, 19.32).
However, very few patients’ scores outside the 95% LOA for both differences. Conclusion: The STAI and BAI are concordances in measuring anxiety levels among these patients. However, the anxiety score using BAI was higher than
STAI. Thus, both assessment tools can be used in clinical practice in measuring anxiety in the out-patients setting.
2.Human Immunodeficiency Virus-infected men who have sex with men with syphilis: A 5-year multicentre study in Malaysia
Siaw Yen Ong ; Min Moon Tang ; Izzaty Dalawi ; Wooi Chiang Tan ; Chin Aun Yeoh ; Wee Meng Kho ; Pubalan Muniandy ; Pui Li Wong ; Rukumani Devi Velayuthan ; Zhenli Kwan ; Chin Chwen Ch&rsquo ; ng ; Norli Marwyne Mohd Noor ; Vijayaletchumi Krishnasamy ; Asmah Johar
The Medical Journal of Malaysia 2020;75(4):349-355
Objectives: High rates of syphilis have been reported
worldwide among men who have sex with men (MSM). This
study aims to describe the clinical pattern and treatment
response of syphilis among human immunodeficiency virus
(HIV)-infected MSM in Malaysia.
Methods: This is a retrospective study on all HIV-infected
MSM with syphilis between 2011 and 2015. Data was collected
from case notes in five centres namely Hospital Kuala Lumpur,
Hospital Sultanah Bahiyah, Hospital Umum Sarawak,
University of Malaya Medical Centre and Hospital Sungai
Buloh.
Results: A total of 294 HIV seropositive MSM with the median
age of 29 years (range 16-66) were confirmed to have syphilis.
Nearly half (47.6%) were in the age group of 20-29 years.
About a quarter (24.1%) was previously infected with syphilis.
Eighty-three patients (28.2%) had other concomitant sexually
transmitted infection with genital warts being the most
frequently reported (17%). The number of patients with early
and late syphilis in our cohort were almost equal. The median
pre-treatment non-treponemal antibody titre (VDRL or RPR)
for early syphilis (1:64) was significantly higher than for late
syphilis (1:8) (p<0.0001). The median CD4 count and the
number of patients with CD4 <200/μl in early syphilis were
comparable to late syphilis. Nearly four-fifth (78.9%) received
benzathine-penicillin only, 5.8% doxycycline, 1.4% Cpenicillin, 1% procaine penicillin, and 12.4% a combination of
the above medications. About 44% received treatment and
were lost to follow-up. Among those who completed 1 -year
follow-up after treatment, 72.3% responded to treatment
(serological non-reactive – 18.2%, four-fold drop in titre –
10.9%; serofast – 43.6%), 8.5% failed treatment and 17% had
re-infection. Excluding those who were re-infected, lost to
follow-up and died, the rates of treatment failure were 12.1%
and 8.8% for early and late syphilis respectively (p=0.582) Conclusion: The most common stage of syphilis among MSM
with HIV was latent syphilis. Overall, about 8.5% failed
treatment at 1-year follow-up.